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Obesity is a worldwide medical problem resulting in serious morbidity and mortality involving
differentiation of pre-adipocytes intomature adipocytes (adipogenesis). Boron treatment has been
reported to be associated with weight reduction in experimental animals; however, its effects on
pre-adipocyte differentiation and anti-adipogenic molecular mechanisms are unknown.
In this study, we demonstrate the inhibitory activities of boric acid (BA) and sodium
pentaborate pentahydrate (NaB) on adipogenesis using common cellular models. Boron
treatment repressed the expression of adipogenesis-related genes and proteins, including
CCAAT-enhancer-binding protein α and peroxisome proliferator-activated receptor γ, by
regulating critical growth factors and the β-catenin, AKT, and extracellular signal-regulated
kinase signaling pathways. In addition, although boron treatment did not induce apoptosis in
pre-adipocytes, it depressed mitotic clonal expansion by regulation of cell cycle genes.
Overall, these data offer promising insights into the prevention/treatment of obesity and
associated diseases.








Obesity and associated comorbidities, such as type 2 diabetes,
hypertension, cardiovascular disease, cancer, and metabolic
syndromeor posttraumatic stress disorder (PTSD), areworldwide
health concerns, particularly in developed countries, leading to
increased healthcare costs, morbidity, and mortality [1,2]. An
estimated 2.1 billion people worldwide are thought to be
overweight or obese, and 2.8 million deaths are associated with
obesity annually [3]. Although the exact molecular mechanisms
of obesity are not well understood, uncontrolled hyperplasia and
hypertrophy of adipocytes, the main units in fat tissue, are
M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L 6 9 ( 2 0 1 7 ) 1 3 0 – 1 4 2
⁎ Corresponding author at: Genetics and Bioengineering Department, Faculty of Engineering and Architecture, Yeditepe University
Kayisdagi, Istanbul, Turkey. Tel.: +90 216 578 0619; fax: +90 216 578 2182.
E-mail addresses: selami.demirci@nih.gov, selamidemirci@hotmail.com (S. Demirci).
1 These authors contributed equally to this work.
http://dx.doi.org/10.1016/j.metabol.2017.01.021
0026-0495/Published by Elsevier Inc.
Ava i l ab l e on l i ne a t www.sc i enced i r ec t . com
Metabolism
www.metabo l i sm jou rna l . com
